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Abstract
Introduction: Iodine is essential for normal fetal and neonatal development. We studied the prevalence and impact on fetal
thyroid development of iodine deficiency in pregnant women in the northern part of the Paris conurbation.
Materials and Methods: 110 patients underwent several determinations of urinary iodine excretion (UIE) and of serum FT4,
FT3, and TSH. Fetal thyroid gland size was assessed using ultrasonography.
Results: We found evidence of widespread iodine deficiency (mean UIE, 49.8 mg/L [standard deviation, 2.11]). Iodine
deficiency did not correlate significantly with maternal thyroid parameters but showed a significant negative correlation
with fetal thyroid gland size (rho=0.25, P=0.02).
Conclusion: Iodine deficiency during pregnancy is still a problem in our geographical area and affects the fetal thyroid
gland. Clinical Trials.gov NCT00162539
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Introduction
During pregnancy, an appropriate supply of iodine is essential
to maintain homeostasis in both the mother and the fetus [1].
Compared with maternal hypothyroidism, iodine deficiency may
have an even greater impact on fetal neurocognitive development
[2,3,4], probably because the area under the curve of fetal blood
thyroxine concentrations is lower. The prevention, early detection,
and immediate correction of iodine or thyroxine deficiency in
pregnant women are high priorities.
Increased size of the neonatal thyroid gland measured using
ultrasonography just after delivery has been reported in infants
born to mothers with iodine deficiency [5]. We have many years of
experience with ultrasonographic fetal thyroid gland measure-
ments. We use both our own unpublished reference curves and the
curves established by Ranzini et al. [6].
France is considered an area of moderate iodine deficiency
[7,8,9]. To date, no consensus has been developed regarding the
appropriateness of iodine supplementation before and during
pregnancy.
The objective of the prospective observational study reported
here was to assess the impact of maternal iodine status on fetal and
neonatal thyroid gland size. We studied pregnant women living in
the northern part of the Paris conurbation and their fetuses and
neonates.
Materials and Methods
Subjects
We planned to recruit 110 pregnant patients receiving routine
prenatal care at a single tertiary-level teaching hospital in northern
Paris, France. Inclusion criteria were normal pregnancy, having
signed the study informed consent document, and being covered by
the French public healthcare insurance system. Exclusion criteria
were the presence of chronic disease; iodine supplementation;
current or past thyroid disease; fetal abnormalities; multiple
pregnancy; pregnancy induced using assisted reproductive technol-
ogy; and abnormal thyroid hormone concentrations at baseline.
Of 129 patients who were invited to participate in the study 4
refused participation and 1 had abnormal serum thyroid hormone
concentrations. Of the remaining 124 patients, 108 (87%)
attended all the study visits. One patient had a miscarriage and
another fetus died in utero at 22 weeks gestational age (WGA).
Five additional patients asked to leave the study later during the
pregnancy, usually at the request of the husband (Figure 1). None
of the study patients delivered prematurely. Cord blood samples
were obtained at delivery from 72 fetuses.
Methods
Study data were collected at four time points: 12 WGA, 22
WGA, 32 WGA, and birth. At the inclusion visit at 12 WGA, a
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ronine (FT3), free thyroxine (F4), and TSH; as well as a urine
sample or a 24 hours collection for determination of urinary
iodine excretion (UIE). At both 22 and 32 WGA, ultrasonography
of the fetal thyroid gland was performed for measurement of
thyroid diameter and circumference. In addition, at 32 WGA a
maternal blood sample was collected for assays of serum FT3,
FT4, TSH, and iodine; as well as a urinary sample or a 24 hours
collection for UIE measurement. Finally, at delivery maternal
blood and cord blood samples were used for assays of FT3, FT4,
and TSH. Ultrasonography of the thyroid gland was performed,
and the results of the neonatal screening test for hypothyroidism
were collected.
Ultrasonography was used to measure the diameter and
circumference of the fetal or neonatal thyroid gland, as previously
described [10,11,12], using an EVB 525 variable-focus ultrasound
machine (Hitachi, Hialeah, FL, USA) with a 3.5-MHz sector
transducer. To minimize variability in fetal thyroid gland diameter
measurements due to differences in fetal size, we normalized fetal
thyroid gland diameter for fetal head circumference.
All blood samples were tested after collection of all study data
was complete. All sera were frozen at 280uC until use. UIE and
serum iodine were assayed in Cerba laboratories using inductively
coupled plasma-mass spectroscopy (Agilent 7500ce, Santa Clara,
CA, USA). The limits of detection were 5 mg/L and 15 mg/L for
serum and urine, respectively. Interassay variability was 7.8% in
serum and 3.5% in urine; intraassay variability was always lower
than interassay variability. UIE was expressed in mg/24 h when a
24-hour urine collection was obtained and in mg/L when a single
urine sample was used. Single samples were always collected in the
morning. Serum iodine was expressed in nanomole per liter.
Serum FT3, FT4, and TSH were assayed in our hospital
laboratory on an ACS-180SE automate, using a chemiluminescent
Figure 1. Flow-chart.
doi:10.1371/journal.pone.0014707.g001
Figure 2. Urinary iodine excretion in pregnant women at 12 GA in the northern part of the Paris conurbation in 2006-2007 (pooled
data). Mean ioduria is 49,8 mg/l +/2 2,1 among 165 samples.
doi:10.1371/journal.pone.0014707.g002
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8.4% for TSH. The limits of detection were 0.3 pm/L, 1.3 pm/L,
and 0.02 IU/L, respectively.
Statistics
To detect a correlation coefficient of 0.3 between UIE and fetal
thyroid size, with alpha set at 2.5% and beta at 10%, 110 patients
were needed.
We previously established reference curves for fetal thyroid
diameter and circumference in our geographic area (unpublished
data). The values were similar to those reported by Ranzini et al
[6]. Previous studies showed endemic iodine deficiency in France
and established mean and median UIE values.
Quantitative variables were described as mean (SD) and
qualitative variables as frequency (percentages). We computed
Spearman’s correlation coefficient to assess correlations linking
maternal thyroid parameters (FT3, FT4, TSH), maternal iodine
status (UIE and serum iodine), and fetal/neonatal thyroid size. All
tests were two-tailed. Statistical analyses were performed using
Statview Software V5 (SAS Institute Inc, Chicago, IL, USA;
Copyright 1992–1998 Version 5.0.) P values less than 0.05 were
considered significant.
The appropriate ethics committee (Comite ´ de Protection des
Personnes d’Ile de France) approved the study protocol on May
12, 2005, under the number 0511132.
Results
Our UIE data obtained at 12 WGA, as well as the pooled UIE
results, indicated iodine deficiency (Figure 2). Thus, the mean
pooled value was 49.8 mg/L (SD, 2.11). UIE values were not
significantly different between 12 WGA and 32 WGA (48.0 [SD,
2 mg/L] and 52.4 [SD 4 mg/L], respectively). UIE was determined
on 24-hour urine collections in one-third of patients and single
urinary samples in the remaining two-thirds. When we compared
UIE values obtained using these two types of urine specimens, we
found slightly higher values in the 24-hour collections (56.4 [SD,
2.8] mg/L) than in the single samples (44.2 [SD 2.5] mg/L); the
difference was statistically significant (P,0.05) but was not
clinically relevant.
Maternal thyroid hormone values at 12 GA were within the
normal ranges for our laboratory (Table 1). As expected, FT3 and
FT4 decreased from 12 to 32 WGA, whereas TSH increased
(Table 1). These variations were not influenced by the UIE nor by
the serum iodine.
At 12 WGA, we found no significant correlations linking FT3,
FT4, TSH, and UIE. A trend was found for high TSH, low T4,
and low UIE. None of the FT3, FT4, or TSH values (12 WGA, 32
WGA, and delivery) correlated significantly with UIE, although a
trend was noted (Table 2).
Fetal thyroid gland size correlated significantly with UIE
considered as a continuous variable or as a categorical variable
(mild vs. severe iodine deficiency). Both the ratio of fetal thyroid
gland diameter over fetal head circumference and UIE were
available for 90 women. In these patients, the fetal thyroid gland
Table 1. Changes in maternal serum levels of free triiodothyronine, free thyroxine, and TSH from 12 weeks’ gestational age to
delivery; cord blood values of the same parameters; and maternal serum iodine and urinary iodine excretion.
Maternal blood Statistics FT3 pmole/L FT4 pmole/L TSH IU/L UIE mg/L
Serum iodine
nmole/L
12 WGA Mean (SD) 4.7 (0.4) 14.1 (1.49) 1.29 (0.63) 48.02 (2) NA
Min-Max
N
3.8–5.7
116
10.4–18.2
116
0.08–3.17
116
30–117
102
32 WGA Mean (SD)
Min-Max
N
4.2 (0.4)
3.3–5.3
96
12.1 (1.5)
8.8–15.5
96
1.62 (0.73)
0.46–4.5
96
52.4 (4)
30–233
63
695 (41)
271–1900
76
Delivery Mean (SD) 4.1 (0.6) 12.2 (1.7) 2.87 (1.5) NA NA
Min-Max
N
1.5–5.2
85
8.7–16.7
85
0.22–9.8
85
Cord Blood Mean (SD) 2.53 (0.08) 14.1(0.2) 7.7 (0.8) NA NA
Min-Max
N
1.5–4.7
72
9.5–19.2
72
0.5–27
72
FT3, free triiodothyronine; FT4, free thyroxine; TSH, thyroid-stimulating hormone; UIE, urinary iodine excretion; WGA, weeks’ gestational age; NA, not available.
doi:10.1371/journal.pone.0014707.t001
Table 2. Correlations between urinary iodine excretion at 12
weeks’ gestational age (WGA) and serum thyroid hormone
levels at 12 and 32 WGA.
12 WGA 32 WGA
FT3 FT4 TSH FT3 FT4 TSH
Thyroid
hormones,
12 WGA
FT3 1
FT4 0.17 1
TSH 20.04 20.19
£ 1
Thyroid
hormones,
32 WGA
FT3 0.41
* 20.11 20.24
& 1
FT4 20.15 0.30
$ 20.24
& 0.09 1
TSH 20.13 20.17 0.56
* 20.07 20.25
& 1
UIE, mg/L, 12
WGA
0.19
£ 0.09 20.02 0.003 0.08 0.01
*p,0.001
$p=0.004
&p=0.02
£0.05,p,0.10
All other p values were above 0.10.
FT3, free triiodothyronine; FT4, free thyroxine; TSH, thyroid-stimulating
hormone; UIE, urinary iodine excretion; WGA, weeks’ gestational age.
doi:10.1371/journal.pone.0014707.t002
Fetal Thyroid and Iodine Input
PLoS ONE | www.plosone.org 3 February 2011 | Volume 6 | Issue 2 | e14707diameter/head circumference ratio showed a significant negative
correlation with UIE (rho= 20.25; P=0.02, Figure 3).
Mean maternal serum iodine at 32 WGA was 695 (SD, 41)
nmole/L, which was normal according to international normative
data [13]. Mean maternal serum iodine at 32 WGA did not
correlate with mean maternal UIE at the same time point but
correlated significantly with the fetal thyroid gland diameter/head
circumference ratio (rho= 20.28; P=0.02) at 32 WGA, with
maternal serum FT4 at 12 WGA (rho=0.37; P=0.001), and with
maternal serum FT4 at 32 WGA (rho=0.36; P=0.02).
The neonatal screening test for hypothyroidism consisted in a
TSH assay on capillary blood on postnatal day 3. The TSH
concentration was below the limit of detection [15 mIU/ml) in all
neonates. TSH, FT4, and FT3 concentrations in cord blood at
delivery are reported in Table 1. Cord blood TSH correlated
significantly with cord blood FT3 (rho= 20.34; P,0.01) and
maternal serum FT4 at 32 WGA (rho= 20.26; P,0.05).
Neonatal thyroid gland measurements were obtained in only
too few babies, which was not sufficient for a valid analysis.
Discussion
The main findings from our prospective observational study in
unselected pregnant women and their fetuses are that iodine
deficiency is widespread in the geographic area served by our
hospital and that lower maternal UIE values are associated with
larger fetal thyroid gland size.
Iodine deficiency is a well-known public health problem in
many parts of the world [14]. Moderate iodine deficiency is
endemic in France, where few data are available regarding the
impact of iodine deficiency on fetal development. Recent
international guidelines indicate that the iodine needs during
pregnancy are higher than previously thought. Although UIE data
indicate iodine deficiency in our study population, only 1 of the
129 women screened for the study had abnormal serum thyroid
hormone levels at 12 WGA. Thus, serum thyroid hormone assays
do not seem useful for detecting iodine deficiency in pregnant
women. Our hospital serves a low-income area where inadequate
nutrition is common. Figure 2 indicates that 100 to 150 mgo f
supplemental iodine per day would not result in UIE values above
the upper limit of the recommended range (500 mg/24 h) in most
women.
We found no significant correlation between maternal serum
thyroid hormone levels and UIE, in contrast to an earlier study
[7]. One possibility is that our population was too homogeneous
regarding the presence and severity of iodine deficiency to show
such a correlation. As expected, serum FT3 and FT4 decreased
and TSH increased over time; however, these three parameters
Figure 3. Correlation between maternal urinary iodine excretion at 12 weeks gestational age (WGA) and the ratio of fetal thyroid
gland diameter over fetal head circumference at 22 weeks gestational age (n=90). R=0,25 p,0,02 n=90.
doi:10.1371/journal.pone.0014707.g003
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conducted in Slovenia, in a place where the iodine supply is
adequate, UIE showed no correlations with maternal serum TSH,
FT4, or FT3 during pregnancy or after delivery [18]. However, in
our study, maternal FT4 at 32 WGA showed a significant negative
correlation with neonatal cord blood TSH, underlining the
importance of maternal FT4 levels for the fetus.
Serum iodine is not considered a valid marker for iodine
deficiency. In our study population, serum iodine levels were
within the normal range, although UIE values indicated iodine
deficiency. In addition, no significant correlation was found
between serum iodine and UIE. Nevertheless, maternal serum
iodine levels showed some correlations with fetal thyroid gland size
and with maternal serum FT4, in keeping with earlier data.
We found a small difference between UIE values in single
samples and 24-hour collections. We have no satisfactory
explanation for this finding. However, the difference is too small
to be clinically relevant and does not detract from our results.
A major finding from our study is that lower maternal UIE
values were associated with a larger size of the fetal thyroid gland.
Thyroid gland hypertrophy in response to iodine deficiency is well
known to occur in adults and in pediatric patients, including
neonates [5]. Our data indicate that the deleterious effect of iodine
deficiency is already detectable during fetal life at least on the size
of the thyroid gland. This is in accordance with what we expect to
be a continuum of deleterious effect of iodine deficiency all life
long including fetal period. Although the women in our study had
iodine deficiency, the cord blood levels of FT3, FT4, and TSH
were within the normal ranges. An earlier study found that
maternal iodine deficiency was associated with increased neonatal
TSH levels between postnatal days 3 and 4 [15]. The number of
neonates who underwent ultrasonography of the thyroid gland was
too small for an evaluation of the potential impact of maternal
iodine deficiency on the neonatal thyroid gland.
Our findings indicate that iodine supplementation should be
offered to all women of childbearing potential and to all pregnant
women in our geographic area. Although iodine supplementation
has been found beneficial even when started only in the second
trimester of pregnancy [16], the benefits are greatest when it is
begun before conception or very early during the pregnancy [17].
Consequently, ultrasonography of the fetal gland is probably not
useful as a screening test for maternal iodine deficiency. Given the
state of our knowledge, a randomized or comparative study of
iodine supplementation would be unethical.
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